title: The binding of oxidized low density lipoprotein to mouse CD36 is mediated in part by oxidized phospholipids that are associated with both the lipid and protein moieties of the lipoprotein.
abstract: There is growing evidence that CD36 has an important physiological function in the uptake of oxidized low density lipoprotein (OxLDL) by macrophages. However, the ligand specificity and the nature of the ligands on OxLDL that mediate the binding to CD36 remain ill defined. Results from recent studies suggested that some of the macrophage scavenger receptors involved in the uptake of OxLDL recognized both the lipid and the protein moieties of OxLDL, but there was no conclusive direct evidence for this. The present studies were undertaken to test whether a single, well characterized OxLDL receptor, CD36, could bind both the lipid and protein moieties of OxLDL. COS-7 cells transiently transfected with mouse CD36 cDNA bound intact OxLDL with high affinity. This binding was very effectively inhibited ( approximately 50%) both by the reconstituted apoB from OxLDL and by microemulsions prepared from OxLDL lipids. The specific binding of both moieties to CD36 was further confirmed by direct ligand binding analysis and by demonstrating reciprocal inhibition, i.e. apoB from OxLDL inhibited the binding of the OxLDL lipids and vice versa. Furthermore, a monoclonal mouse antibody that recognizes oxidation-specific epitopes in OxLDL inhibited the binding of intact OxLDL and also that of its purified protein and lipid moieties to CD36. This antibody recognizes the phospholipid 1-palmitoyl 2-(5'-oxovaleroyl) phosphatidylcholine. This model of an oxidized phospholipid was also an effective competitor for the CD36 binding of both the resolubilized apoB and the lipid microemulsions from OxLDL. Our results demonstrate that oxidized phospholipids in the lipid phase or covalently attached to apoB serve as ligands for recognition by CD36 and, at least in part, mediate the high affinity binding of OxLDL to macrophages.
authors.affiliation: Department of Medicine, University of California, San Diego, La Jolla, California 92093-0682, USA.
authors.forename: A
authors.initials: A
authors.lastname: Boullier
authors.forename: K L
authors.initials: KL
authors.lastname: Gillotte
authors.forename: S
authors.initials: S
authors.lastname: Hörkkö
authors.forename: S R
authors.initials: SR
authors.lastname: Green
authors.forename: P
authors.initials: P
authors.lastname: Friedman
authors.forename: E A
authors.initials: EA
authors.lastname: Dennis
authors.forename: J L
authors.initials: JL
authors.lastname: Witztum
authors.forename: D
authors.initials: D
authors.lastname: Steinberg
authors.forename: O
authors.initials: O
authors.lastname: Quehenberger
mesh_terms: D000818:Animals; D018955:CD36 Antigens / Q000235:genetics / Q000378:metabolism*; D019556:COS Cells; D008024:Ligands; D008077:Lipoproteins, LDL / Q000737:chemistry / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism*; D011485:Protein Binding; D014162:Transfection
chemical_list: D018955:CD36 Antigens; D008024:Ligands; D008077:Lipoproteins, LDL; D010743:Phospholipids; C099252:oxidized low density lipoprotein